학술논문
A phase II, prospective, randomized, open-label study of defibrotide added to standard-of-care prophylaxis for the prevention of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation
Document Type
Article
Author
Source
In: Haematologica . (Haematologica, April 2023, 108(4):1026-1038)
Subject
Language
English
ISSN
15928721
03906078
03906078